Opportunity Information: Apply for PA 18 937
The National Institutes of Health (NIH) funding opportunity titled "Research on Chronic Overlapping Pain Conditions (R01 Clinical Trial Optional)" (Funding Opportunity Number: PA 18-937) supports research aimed at explaining why many people with chronic pain do not fit neatly into a single diagnosis. Instead, they often experience multiple chronic pain conditions at the same time, share symptoms across conditions, or move from one diagnostic category to another over time. The program is designed to fund epidemiological, clinical, and translational studies that clarify how common these overlaps are, how they develop, what biological and psychological processes drive them, and which clinical factors increase risk.
A central theme of the opportunity is improving understanding of the natural history of chronic overlapping pain conditions. That includes tracking when and how overlapping conditions begin, identifying patterns of progression, and describing how overlaps evolve across the lifespan or across stages of illness. NIH is looking for work that can sort out underlying etiologies and mechanisms, such as shared biological pathways, nervous system changes, immune or inflammatory contributions, genetic or epigenetic influences, and other mechanistic explanations that might account for why different pain conditions cluster in the same individuals. At the same time, the FOA emphasizes psychological variables and clinical risk factors, reflecting an interest in how factors like mood, stress responses, trauma exposure, sleep problems, cognitive and behavioral processes, and health care experiences may contribute to comorbidity and persistence.
The announcement also highlights a practical goal: improving treatment strategies for people who live with multiple chronic pain conditions. Because clinical care is often organized around single-diagnosis models, patients with overlapping conditions may not respond well to standard approaches. NIH is therefore encouraging projects that can inform which therapeutic approaches are best suited for individuals with overlapping pain presentations, including studies that test or refine intervention strategies. The "clinical trial optional" designation means applicants may propose studies with or without a clinical trial component, depending on what best addresses the scientific question.
Another major objective is team science and deliberate cross-disciplinary collaboration. NIH wants applicants to build research groups that bridge expertise in pain mechanisms with translational and clinical expertise, so that findings can move more effectively between basic discovery, patient-oriented research, and real-world clinical relevance. Applicants are encouraged to leverage existing resources (such as established cohorts, registries, biobanks, data repositories, or clinical networks) and to develop new resources that strengthen the field's capacity to study chronic overlapping pain conditions. The FOA also explicitly encourages including investigators from outside the traditional pain research field when their expertise would broaden perspectives or introduce new methods, such as computational biology, systems neuroscience, immunology, psychiatry, epidemiology, behavioral science, data science, or implementation research.
In terms of eligibility, the opportunity is broadly open to many types of applicants. Eligible organizations include state and local governments, public and private institutions of higher education, nonprofit organizations (with or without 501(c)(3) status), for-profit organizations (other than small businesses) and small businesses, independent school districts, special district governments, and public housing authorities/Indian housing authorities. It also includes federally recognized tribal governments and other Native American tribal organizations. In addition, the FOA calls out a wide set of other eligible applicants, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, U.S. territories or possessions, and non-U.S. entities (foreign organizations), as well as regional organizations and tribal governments that are not federally recognized.
Administratively, this is an NIH discretionary grant using the R01 mechanism, under the health funding activity category. The listing includes multiple CFDA numbers (93.121, 93.213, 93.273, 93.313, 93.846, 93.853), reflecting involvement across NIH programs that support pain and related research areas. The opportunity was created on September 26, 2018, and the source record notes an original closing date of May 7, 2022. The provided record does not specify an award ceiling or expected number of awards, suggesting applicants would need to refer to the full FOA details and NIH institute-specific participation for budget expectations and award volumes.Apply for PA 18 937
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Research on Chronic Overlapping Pain Conditions (R01 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.121, 93.213, 93.273, 93.313, 93.846, 93.853.
- This funding opportunity was created on 2018-09-26.
- Applicants must submit their applications by 2022-05-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the title of this NIH funding opportunity?
The opportunity is titled "Research on Chronic Overlapping Pain Conditions (R01 Clinical Trial Optional)".
What is the Funding Opportunity Number (FOA number)?
The Funding Opportunity Number listed is PA 18-937.
What is the main purpose of this grant opportunity?
This NIH program supports research that explains why many people with chronic pain do not fit neatly into a single diagnosis. It focuses on situations where individuals experience multiple chronic pain conditions at the same time, share symptoms across conditions, or shift from one diagnostic category to another over time.
What types of studies does the FOA aim to fund?
The FOA is designed to fund epidemiological, clinical, and translational studies. The emphasis is on clarifying how common chronic overlapping pain conditions are, how they develop, what processes drive them, and which clinical factors increase risk.
What are "chronic overlapping pain conditions" in the context of this FOA?
Based on the description provided, chronic overlapping pain conditions refer to chronic pain presentations where multiple pain conditions co-occur, symptoms overlap across conditions, and/or an individual may move between diagnostic categories over time rather than remaining in a single stable diagnosis.
What does the FOA mean by understanding the "natural history" of overlapping pain conditions?
The FOA highlights the need to improve understanding of the natural history of these conditions, including tracking when and how overlapping conditions begin, identifying progression patterns, and describing how overlaps evolve across the lifespan or across stages of illness.
Does NIH want research focused on underlying causes and mechanisms?
Yes. A key objective is sorting out underlying etiologies and mechanisms that might explain why different pain conditions cluster in the same individuals. Examples mentioned include shared biological pathways, nervous system changes, immune or inflammatory contributions, and genetic or epigenetic influences.
Are psychological and behavioral factors within scope?
Yes. The FOA emphasizes psychological variables and clinical risk factors, including factors such as mood, stress responses, trauma exposure, sleep problems, cognitive and behavioral processes, and health care experiences that may contribute to comorbidity and persistence.
Is the FOA interested in research that improves treatment for patients with multiple chronic pain conditions?
Yes. The announcement highlights a practical goal of improving treatment strategies for people living with multiple chronic pain conditions, recognizing that care is often organized around single-diagnosis models and may not work well for overlapping presentations.
Can applicants propose intervention studies under this FOA?
Yes. The FOA encourages projects that can inform which therapeutic approaches are best suited for individuals with overlapping pain presentations, including studies that test or refine intervention strategies.
What does "Clinical Trial Optional" mean for this opportunity?
"Clinical trial optional" means applicants may propose studies with or without a clinical trial component, depending on what best addresses the proposed scientific question.
What grant mechanism is being used?
This is an NIH discretionary grant using the R01 mechanism.
What is the funding activity category?
The listing describes this as a health funding activity category.
Does this FOA encourage team science or cross-disciplinary collaboration?
Yes. A major objective is team science and deliberate cross-disciplinary collaboration, bridging expertise in pain mechanisms with translational and clinical expertise so findings can move between basic discovery, patient-oriented research, and real-world clinical relevance.
Are applicants encouraged to use existing cohorts, registries, or other shared resources?
Yes. The FOA encourages leveraging existing resources such as established cohorts, registries, biobanks, data repositories, or clinical networks, and also supports developing new resources that strengthen the field's capacity to study chronic overlapping pain conditions.
Does NIH encourage participation by researchers outside the traditional pain field?
Yes. The FOA explicitly encourages including investigators from outside traditional pain research when their expertise broadens perspectives or introduces new methods. Examples given include computational biology, systems neuroscience, immunology, psychiatry, epidemiology, behavioral science, data science, and implementation research.
Which organizations are eligible to apply?
The FOA is broadly open to many applicant types, including:
- State and local governments
- Public and private institutions of higher education
- Nonprofit organizations (with or without 501(c)(3) status)
- For-profit organizations (other than small businesses) and small businesses
- Independent school districts
- Special district governments
- Public housing authorities/Indian housing authorities
- Federally recognized tribal governments and other Native American tribal organizations
- U.S. territories or possessions
- Eligible federal agencies
- Non-U.S. entities (foreign organizations)
- Regional organizations
- Tribal governments that are not federally recognized
Are minority-serving institutions and community-based organizations specifically mentioned as eligible?
Yes. The FOA calls out eligibility for a wide set of organizations including Alaska Native and Native Hawaiian Serving Institutions, AANAPISIs, Hispanic-serving Institutions, HBCUs, TCCUs, as well as faith-based or community-based organizations.
Are foreign organizations eligible to apply?
Yes. The eligibility list explicitly includes non-U.S. entities (foreign organizations).
What CFDA numbers are associated with this opportunity?
The listing includes multiple CFDA numbers: 93.121, 93.213, 93.273, 93.313, 93.846, and 93.853. This suggests involvement across NIH programs supporting pain and related research areas.
When was this opportunity created?
The opportunity was created on September 26, 2018.
What is the closing date shown in the provided record?
The source record notes an original closing date of May 7, 2022.
Does the provided record list an award ceiling or the expected number of awards?
No. The provided record does not specify an award ceiling or expected number of awards, and it indicates applicants would need to refer to the full FOA details and NIH institute-specific participation for budget expectations and likely award volume.
Is this FOA focused only on single-condition pain research?
No. The central theme is that many people experience multiple chronic pain conditions, share symptoms across conditions, or move between diagnostic categories, and the FOA is focused on understanding and addressing those overlaps.
Browse more opportunities from the same category: Health
Next opportunity: Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Optional)
Previous opportunity: Regenerative Medicine Innovation Projects (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 18 937
Applicants also applied for:
Applicants who have applied for this opportunity (PA 18 937) also looked into and applied for these:
| Funding Opportunity |
|---|
| Clinical and Translational Science Award (U54 Clinical Trial Optional) Apply for PAR 18 940 Funding Number: PAR 18 940 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Optional) Apply for PAR 18 941 Funding Number: PAR 18 941 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Optional) Apply for PAR 18 942 Funding Number: PAR 18 942 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Leadership Group for an Infectious Diseases Clinical Research Consortium (IDCRC) (UM1 Clinical Trial Required) Apply for RFA AI 18 047 Funding Number: RFA AI 18 047 Agency: National Institutes of Health Category: Health Funding Amount: $1,700,000 |
| Dysregulation and Proximal Risk for Suicide FOA (R01 Clinical Trial Optional) Apply for RFA MH 19 211 Funding Number: RFA MH 19 211 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Voluntary Family Planning for Improved Reproductive Health and Development. Apply for RFI 617 19 FAMILY PLANNING Funding Number: RFI 617 19 FAMILY PLANNING Agency: Uganda USAID-Kampala Category: Health Funding Amount: Case Dependent |
| Vaccine and Treatment Evaluation Units (VTEUs) (UM1 Clinical Trial Required) Apply for RFA AI 18 046 Funding Number: RFA AI 18 046 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Social and Behaviour Change for Transformation (SBC4T) Apply for RFI 617 19 SBC4T Funding Number: RFI 617 19 SBC4T Agency: Uganda USAID-Kampala Category: Health Funding Amount: Case Dependent |
| Dysregulation and Proximal Risk for Suicide (R21 Clinical Trial Optional) Apply for RFA MH 19 210 Funding Number: RFA MH 19 210 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Fc-Dependent Mechanisms of Antibody-Mediated Killing (U01 Clinical Trial Not Allowed) Apply for RFA AI 18 042 Funding Number: RFA AI 18 042 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Fc-Dependent Mechanisms of Antibody-Mediated Killing (R21 Clinical Trial Not Allowed) Apply for PA 19 020 Funding Number: PA 19 020 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| APS-OAA-16-000001 Addendum Ukraine Health Apply for 72012119RFA00001 Funding Number: 72012119RFA00001 Agency: Ukraine USAID-Kiev Category: Health Funding Amount: $3,000,000 |
| Specialized Alcohol Research Centers Clinical Trial Optional (P50 Clinical Trial Optional) Apply for RFA AA 19 004 Funding Number: RFA AA 19 004 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| Advancing Imaging, Device Production, and Clinical Capabilities in Digital Dentistry (R41/R42 Clinical Trial Not Allowed) Apply for PA 19 021 Funding Number: PA 19 021 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Radiation Biodosimetry Assays and Devices (U01 Clinical Trial Not Allowed) Apply for RFA AI 18 045 Funding Number: RFA AI 18 045 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Health-professional Education Partnership Initiative (HEPI) (R25 Clinical Trial Not Allowed) Apply for RFA TW 18 002 Funding Number: RFA TW 18 002 Agency: National Institutes of Health Category: Health Funding Amount: $600,000 |
| Advancing Imaging, Device Production, and Clinical Capabilities in Digital Dentistry (R43/R44 Clinical Trial Not Allowed) Apply for PA 19 022 Funding Number: PA 19 022 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Basic Neurodevelopmental Biology of Brain Circuits and Behavior (R21 Clinical Trial Not Allowed) Apply for PAR 19 028 Funding Number: PAR 19 028 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Basic Neurodevelopmental Biology of Circuits and Behavior (R01 Clinical Trial Not Allowed) Apply for PAR 19 027 Funding Number: PAR 19 027 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Administrative Supplements for Complementary Health Practitioner Research Experience (Admin Supp Clinical Trial Optional) Apply for PA 19 031 Funding Number: PA 19 031 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 18 937", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.